Physician profile
Roderick E Brown
NPI 1104933779
$1,181.06
in general payments reported to CMS, 2019-2025
9 companies · $369 in 2025
The $369 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.89 · 2020: $11.49 · 2021: $78.86 · 2022: $144 · 2023: $240 · 2024: $255 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $372.84 | 2023-2025 | Octrode, Eterna, Proclaim |
| Boston Scientific Corporation | $327.53 | 2023-2025 | Wavewriter Alpha Prime 16, Intracept |
| Medtronic, INC. | $152.88 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $100.61 | 2021-2025 | Tecnis Iol, Catalys System, Tecnis Simplicity |
| Glaukos Corporation | $82.89 | 2019 | |
| Abbvie INC. | $51.02 | 2023 | Durysta |
| Saluda Medical Americas, INC. | $49.93 | 2022-2025 | Evoke, Evoke Scs |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.91 | 2020-2021 | |
| Carl Zeiss Meditec USA, INC. | $20.45 | 2024 | Lumera 700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roderick Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.